MetLife Misses Targets

WebMD chooses new CEO; FDA clears AstraZeneca lung cancer drug; plus more of today's stocks in the news

After the close of trade Monday, insurance and financial services giant MetLife (MET ) posted 47 cents earnings per share vs. 44 cents for the first quarter. Excluding an after-tax net investment loss, and before an accounting change, MetLife reported 62 cents earnings per share -- missing analysts' estimates by three cents. Revenues rose 5% to $8.38 billion.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.